KR20240132479A - 우울증 치료를 위한 조성물 및 방법 - Google Patents
우울증 치료를 위한 조성물 및 방법 Download PDFInfo
- Publication number
- KR20240132479A KR20240132479A KR1020247026164A KR20247026164A KR20240132479A KR 20240132479 A KR20240132479 A KR 20240132479A KR 1020247026164 A KR1020247026164 A KR 1020247026164A KR 20247026164 A KR20247026164 A KR 20247026164A KR 20240132479 A KR20240132479 A KR 20240132479A
- Authority
- KR
- South Korea
- Prior art keywords
- level
- patient
- baseline
- dynorphin
- articaprant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298047P | 2022-01-10 | 2022-01-10 | |
| US63/298,047 | 2022-01-10 | ||
| PCT/IB2023/050170 WO2023131920A1 (en) | 2022-01-10 | 2023-01-09 | Compositions and methods for the treatment of depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240132479A true KR20240132479A (ko) | 2024-09-03 |
Family
ID=84981555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247026164A Pending KR20240132479A (ko) | 2022-01-10 | 2023-01-09 | 우울증 치료를 위한 조성물 및 방법 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250221960A1 (https=) |
| EP (1) | EP4463152A1 (https=) |
| JP (1) | JP2025503646A (https=) |
| KR (1) | KR20240132479A (https=) |
| CN (1) | CN118510507A (https=) |
| AU (1) | AU2023205471A1 (https=) |
| CA (1) | CA3247760A1 (https=) |
| IL (1) | IL314179A (https=) |
| MX (1) | MX2024008618A (https=) |
| WO (1) | WO2023131920A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024336807A1 (en) * | 2023-09-06 | 2026-04-16 | Janssen Pharmaceuticals, Inc. | Compositions comprising aticaprant for use in treating major depressive disorder |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5345637B2 (ja) * | 2008-01-22 | 2013-11-20 | イーライ リリー アンド カンパニー | κ選択的オピオイド受容体アンタゴニスト |
-
2023
- 2023-01-09 MX MX2024008618A patent/MX2024008618A/es unknown
- 2023-01-09 IL IL314179A patent/IL314179A/en unknown
- 2023-01-09 CN CN202380016647.0A patent/CN118510507A/zh active Pending
- 2023-01-09 US US18/727,772 patent/US20250221960A1/en active Pending
- 2023-01-09 WO PCT/IB2023/050170 patent/WO2023131920A1/en not_active Ceased
- 2023-01-09 AU AU2023205471A patent/AU2023205471A1/en active Pending
- 2023-01-09 JP JP2024541193A patent/JP2025503646A/ja active Pending
- 2023-01-09 CA CA3247760A patent/CA3247760A1/en active Pending
- 2023-01-09 EP EP23700339.7A patent/EP4463152A1/en active Pending
- 2023-01-09 KR KR1020247026164A patent/KR20240132479A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4463152A1 (en) | 2024-11-20 |
| CN118510507A (zh) | 2024-08-16 |
| JP2025503646A (ja) | 2025-02-04 |
| WO2023131920A1 (en) | 2023-07-13 |
| IL314179A (en) | 2024-09-01 |
| CA3247760A1 (en) | 2023-07-13 |
| US20250221960A1 (en) | 2025-07-10 |
| AU2023205471A1 (en) | 2024-08-29 |
| MX2024008618A (es) | 2024-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240004857A (ko) | 우울증 치료를 위한 조성물 및 방법 | |
| JP6545788B2 (ja) | うつ病の治療方法 | |
| US12150929B2 (en) | Compositions and methods for the treatment of depression | |
| CA3086478A1 (en) | Esketamine for the treatment of depression | |
| CN104519878A (zh) | 用于治疗顽固性或难治性抑郁症的艾氯胺酮 | |
| JP2025508069A (ja) | アチカプラントを含む組成物 | |
| JP2012522033A (ja) | 気分障害の治療における低用量ピパンペロン | |
| KR20240132479A (ko) | 우울증 치료를 위한 조성물 및 방법 | |
| KR20240132501A (ko) | 우울증 치료를 위한 조성물 및 방법 | |
| US20250177350A1 (en) | Compositions and methods for the treatment of depression | |
| US20240238245A1 (en) | Compositions and methods for the treatment of depression | |
| JP2025502098A (ja) | うつ病の治療のための組成物及び方法 | |
| CN117615757A (zh) | 用于治疗抑郁症的组合物和方法 | |
| EA050800B1 (ru) | Композиции и способы лечения депрессии | |
| JP7840873B2 (ja) | うつ病の治療方法 | |
| Walitza et al. | Psychostimulants and other drugs used in the treatment of attention-deficit/hyperactivity disorder (ADHD) | |
| WO2024211216A1 (en) | Cilnidipine and a p-glycoprotein inhibitor for treating pain | |
| López-Muñoz et al. | Combination strategies in treatment-resistant depression | |
| Roller et al. | Disease state management: Mood disorders: Part one: Depression and antidepressants | |
| Ionescu et al. | Efficacy and tolerability of risperidone in the treatment of depressive disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20240802 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application |